Traditional Chinese medicine health food product with efficacy of blood glucose reduction and preparation process of traditional Chinese medicine health food product

Abstract

The invention discloses a hypoglycemic traditional Chinese medicine health food. The formula of the hypoglycemic traditional Chinese medicine health food is as follows: 5-8 parts of Ophiopogon japonicus, 12-16 parts of astragalus, 9-14 parts of donkey-hide gelatin, 14-18 parts of kudzu root, 7‑10 parts of medlar, 3‑5 parts of hijiki, 2‑4 parts of American ginseng, 4‑7 parts of Polygonatum odoratum, 5‑9 parts of ginkgo biloba, 1‑3 parts of rehmannia, 2‑5 parts of anemarrhena, privet fruit 7‑9 servings. The invention is made of astragalus, donkey-hide gelatin, kudzu root, medlar, American ginseng, ginkgo leaf, Anemarrhena anemarrhena, and Ligustrum lucidum as main components. The invention can effectively reduce blood sugar and lower blood sugar. Dependence is produced, and no adverse reaction occurs, the preparation process is simple, the cost is low, and industrial production can be realized.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine health care, in particular to a blood sugar-lowering traditional Chinese medicine health food and a preparation process thereof. Background technique [0002] Hypertension is the most common cardiovascular disease, and its incidence increases with age. It is estimated that about 26% of the global population suffers from high blood pressure, but the incidence rate doubles to about 50% in those aged 60-69 and reaches 75% in those over 70 years old. In 1992, the prevalence rate of hypertension in my country was 11.6%, but at present in my country, the incidence rate of hypertension is as high as 27%, and the number is close to 130 million. Hypertension can easily cause complications of the heart, brain, kidney and other organs, seriously endangering human health, with high mortality and disability rates. In the process of clinical treatment of hypertension, western medicine acts...

AI Technical Summary

Problems solved by technology

Therefore, a single antihypertensive treatment is often ineffective, and blood lipids and blood sugar should be effectively controlled, that is, lipid-lowering drugs and hypoglycemic drugs should be added.

However, the simultaneous use of the three types of drugs not only increases the cost of treatment for patients, but also may cause adverse reactions due to drug interactions and increase the physical burden of patients.